Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II, Double-blind, Placebo-controlled Study Assessing the Safety and Efficacy of AVX-012 Ophthalmic Solution in Subjects With Mild-to-moderate Dry Eye Syndrome

NCT03162094 is registered in ClinicalTrials.gov with Avizorex Pharma, S.L. as lead sponsor.

NCT NCT03162094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03162094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II, Double-blind, Placebo-controlled Study Assessing the Safety and Efficacy of AVX-012 Ophthalmic Solution in Subjects With Mild-to-moderate Dry Eye Syndrome
Lead sponsor
Avizorex Pharma, S.L.
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 3, 2017
Completion date
December 31, 2018
Enrollment
172 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome